The abundance of Bacteroidales, Bifidobacteriaceae, Lachnospiraceae, Prevotellaceae, and Turicibacteraceae was higher in HER2-positive breast cancer patients responsive to trastuzumab treatment than nonresponsive patients. This evidence concerns the gene ERBB2 and breast carcinoma.